AMD - Age-Related Macular Degeneration
11
4
4
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (11)
Photobiomodulation Laser for Reticular Pseudodrusen in Age-Related Macular Degeneration
Prognostic Role of Macular Neovascular Membrane Subtype in Pneumatic Displacement of Macular Hemorrhages
Study in Human iPSCs-derived RPE Cells Transplantation for Late-Stage AMD
Repeated Low-Level Red-Light Therapy in Dry Age-Related Macular Degeneration
A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses
Comparison of the Sensibility of Swept Source Optical Coherence Tomography Devices in the Detection of Neovascularisation in Large Pigment Epithelium Detachments
"My Eyes, My Light": Amar Chokh, Amar Alo
The Impact of Artificial Lighting on the Visual Capacity of Patients With Age-Related Macular Degeneration
Visual Rehabilitation and Depression in Visually Impaired Patients with AMD
Retinal Investigation Using Optos OCT Device
NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients